Gilead Sciences, Inc. v. ProAct, Inc.
| GILEAD SCIENCES, INC. and GILEAD SCIENCES IRELAND UC IDA |
| PROACT, INC., MERITAIN HEALTH, INC., RX VALET, LLC, ADVANCED PHARMACY, LLC, AQUA ENTERPRISE INC., d/b/a Affordable RX Meds, GREGORY SANTULLI and FETIH ECZANESI |
| HEALTHHIV, THE ADAP ADVOCACY ASSOCIATION, THE AUTOIMMUNE ASSOCIATION, THE HIV AND HEPATITIS POLICY INSTITUTE and THE INTERNATIONAL FOUNDATION FOR AUTOIMMUNE & AUTOINFLAMMATORY ARTHRITIS |
| 25-1829 |
| July 21, 2025 |
| U.S. Court of Appeals, Fourth Circuit |
| Trademark |
Docket Report
This docket was last retrieved on January 15, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 59 COURT ORDER filed granting Motion to file amicus curiae brief [ # 50 ]. Appearance form due on 01/20/2026 from William Anthony Sarraille. Disclosure statement due from HealthHIV, The ADAP Advocacy Association, The Autoimmune Association, The HIV and Hepatitis Policy Institute and The International Foundation for Autoimmune & Autoinflammatory Arthritison 01/20/2026. Disclosure Statement filed (if corporate amicus)? N. Appearance Form filed? N. Copies to all parties.. [1001909792] [25-1828, 25-1829, 25-1849, 25-1850] RP [Entered: 01/15/2026 10:02 AM] |
| Filing 58 MOTION by Advanced Pharmacy, LLC, Aqua Enterprise Inc. and RX Valet, LLC in 25-1849, Gregory Santulli in 25-1850 to extend filing time for reply brief pending ruling on Motion for Leave to File Amicus Brief (Dkt. No. 55) until February 13, 2026, or 30 days after ruling on the Motion for Leave. , to exceed length limitations for reply. Date and method of service: 01/14/2026 ecf. [1001909647] [25-1828, 25-1829, 25-1849, 25-1850] Michael Beltran [Entered: 01/14/2026 11:24 PM] |
| Filing 57 REPLY by HealthHIV, The ADAP Advocacy Association, The Autoimmune Association, The HIV and Hepatitis Policy Institute and The International Foundation for Autoimmune & Autoinflammatory Arthritis in 25-1828, 25-1829, 25-1849, 25-1850 to docket correction [ # 56 ].. [1001906890] [25-1828, 25-1829, 25-1849, 25-1850] William Sarraille [Entered: 01/12/2026 09:24 AM] |
| Filing 56 Docket correction requested from HealthHIV, The ADAP Advocacy Association, The Autoimmune Association, The HIV and Hepatitis Policy Institute and The International Foundation for Autoimmune & Autoinflammatory Arthritis in 25-1828, 25-1829, 25-1849, 25-1850. Re: [ # 55 ] memorandum reply brief. Access to memorandum reply brief has been restricted to case participants. [1001906791] [25-1828, 25-1829, 25-1849, 25-1850] RP [Entered: 01/12/2026 08:27 AM] |
| Filing 55 MEMORANDUM REPLY BRIEF by HealthHIV, The ADAP Advocacy Association, The Autoimmune Association, The HIV and Hepatitis Policy Institute and The International Foundation for Autoimmune & Autoinflammatory Arthritis in 25-1828, 25-1829, 25-1849, 25-1850. Do any cases pending in this court or the Supreme Court of the United States raise similar issues? NO.. [1001906708] [25-1828, 25-1829, 25-1849, 25-1850] William Sarraille [Entered: 01/09/2026 05:08 PM] |
| Filing 54 RESPONSE/ANSWER by Meritain Health, Inc. in 25-1828 to notice requesting response [ # 51 ], Motion to approve/authorize [ # 50 ]. Nature of response: in opposition. [1001905340] [25-1828, 25-1829, 25-1849, 25-1850] Ellen Matheson [Entered: 01/08/2026 11:49 AM] |
| Filing 53 AMICUS CURIAE BRIEF by HealthHIV, The ADAP Advocacy Association, The Autoimmune Association, The International Foundation for Autoimmune & Autoinflammatory Arthritis and The HIV and Hepatitis Policy Institute in 25-1828, 25-1829, 25-1849, 25-1850. . Do any cases pending in this court or the Supreme Court of the United States raise similar issues? NO.. [1001900191] [25-1828, 25-1829, 25-1849, 25-1850] William Sarraille [Entered: 12/29/2025 03:55 PM] |
| Filing 52 Docket correction requested re: filing of amicus brief separately from HealthHIV, The ADAP Advocacy Association, The Autoimmune Association, The HIV and Hepatitis Policy Institute and The International Foundation for Autoimmune & Autoinflammatory Arthritis in 25-1828, 25-1829, 25-1849, 25-1850. [1001899853] [25-1828, 25-1829, 25-1849, 25-1850] RP [Entered: 12/29/2025 11:50 AM] |
| Filing 51 NOTICE ISSUED to Meritain Health, Inc. in 25-1828 requesting response to Motion to approve/authorize [ # 50 ]. Response due 01/08/2026[1001899850]. [25-1828, 25-1829, 25-1849, 25-1850] RP [Entered: 12/29/2025 11:48 AM] |
| Filing 50 MOTION by The HIV and Hepatitis Policy Institute, The ADAP Advocacy Association, The International Foundation for Autoimmune & Autoinflammatory Arthritis, The Autoimmune Association, and HealthHIV to file amicus curiae brief without consent of all parties on appeal within time allowed by FRAP 29(e). Date and method of service: 12/26/2025 ecf. [1001899480] [25-1828, 25-1829, 25-1849, 25-1850].--[Edited 01/08/2026 by AB to modify relief and docket text] William Sarraille [Entered: 12/26/2025 11:50 AM] |
Filing 49
ORDER filed sealing response brief. Copies to all parties. [1001897867] [25-1828, 25-1829, 25-1849, 25-1850] RP [Entered: 12/22/2025 10:06 AM]
|
| Filing 48 Redacted BRIEF by Gilead Sciences, Inc. and Gilead Sciences Ireland UC IDA in 25-1828, 25-1829, 25-1849, 25-1850. Type of Brief: RESPONSE. . Do any cases pending in this court or the Supreme Court of the United States raise similar issues? NO.. [1001897600] [25-1828, 25-1829, 25-1849, 25-1850] Geoffrey Potter [Entered: 12/19/2025 06:13 PM] |
| Filing 47 CERTIFICATE OF CONFIDENTIALITY (Local Rule 25(c)) by Gilead Sciences, Inc. and Gilead Sciences Ireland UC IDA in 25-1828, 25-1829, 25-1849, 25-1850. Sealing Required: Yes. Description of document referenced by certificate: Brief for Plaintiffs-Appellees (Sealed). [1001897598] [25-1828, 25-1829, 25-1849, 25-1850] Geoffrey Potter [Entered: 12/19/2025 06:12 PM] |
| Filing 46 SEALED BRIEF (court access only) by Gilead Sciences, Inc. and Gilead Sciences Ireland UC IDA in 25-1828, 25-1829, 25-1849, 25-1850 . Type of Brief: SEALED RESPONSE. . Filed Ex parte: N. Do any cases pending in this court or the Supreme Court of the United States raise similar issues? NO.. [1001897597] [25-1828, 25-1829, 25-1849, 25-1850] Geoffrey Potter [Entered: 12/19/2025 06:10 PM] |
Filing 45
ORDER filed granting Motion to extend filing time [ # 44 ] Number of days granted: 21. Response brief due 12/19/2025. Any Reply brief due 01/30/2026. No paper copies required unless case has been tentatively calendared or copies otherwise ordered. Copies to all parties. [1001879107] [25-1828, 25-1829, 25-1849, 25-1850] RP [Entered: 11/17/2025 05:08 PM]
|
| Filing 44 MOTION by Gilead Sciences, Inc. in 25-1828, 25-1829, 25-1849, 25-1850 to extend filing time for Briefing.. Date and method of service: 11/17/2025 ecf. [1001878757] [25-1828, 25-1829, 25-1849, 25-1850] Geoffrey Potter [Entered: 11/17/2025 01:47 PM] |
| Filing 43 COURT ORDER filed granting Motion to file separate reply briefs [ # 42 ]. Copies to all parties. [1001877132] [25-1828, 25-1829, 25-1849, 25-1850] RP [Entered: 11/13/2025 02:58 PM] |
| Filing 42 MOTION by Meritain Health, Inc. in 25-1828 to file separate briefs [42]. Date and method of service: 11/11/2025 ecf. [1001875545] [25-1828, 25-1829, 25-1849, 25-1850] Ellen Matheson [Entered: 11/11/2025 04:06 PM] |
| Filing 41 APPEARANCE OF COUNSEL by Steven M. Klepper for Gilead Sciences Ireland UC IDA and Gilead Sciences, Inc. in 25-1828, 25-1829, 25-1849, 25-1850. [1001859655] [25-1828, 25-1829, 25-1849, 25-1850] Steven Klepper [Entered: 10/14/2025 02:55 PM] |
Filing 40
ORDER filed sealing opening brief by by Advanced Pharmacy, LLC, Aqua Enterprise Inc. and RX Valet, LLC in 25-1849, Gregory Santulli in 25-1850 and joint appendix volumes 7-13. Copies to all parties. [1001859536] [25-1828, 25-1829, 25-1849, 25-1850] RP [Entered: 10/14/2025 01:16 PM]
|
| Filing 39 CERTIFICATE OF CONFIDENTIALITY (Local Rule 25(c)) by Advanced Pharmacy, LLC, Aqua Enterprise Inc. and RX Valet, LLC in 25-1849, Gregory Santulli in 25-1850. Sealing Required: No. Description of document referenced by certificate: Sealed Opening Brief of Rx Valet, Advanced Pharmacy, Aqua Enterprise, Inc., and Gregory Santulli. [1001858908] [25-1849, 25-1828, 25-1829, 25-1850] Michael Beltran [Entered: 10/10/2025 10:55 PM] |
| Filing 38 SEALED BRIEF (court access only) by Advanced Pharmacy, LLC, Aqua Enterprise Inc. and RX Valet, LLC in 25-1849, Gregory Santulli in 25-1850 . Type of Brief: SEALED OPENING. . Filed Ex parte: N. Do any cases pending in this court or the Supreme Court of the United States raise similar issues? NO.. [1001858907] [25-1849, 25-1828, 25-1829, 25-1850] Michael Beltran [Entered: 10/10/2025 10:53 PM] |
| Filing 37 BRIEF by Advanced Pharmacy, LLC, Aqua Enterprise Inc. and RX Valet, LLC in 25-1849, Gregory Santulli in 25-1850. Type of Brief: OPENING. . Do any cases pending in this court or the Supreme Court of the United States raise similar issues? NO.. [1001858906] [25-1849, 25-1828, 25-1829, 25-1850] Michael Beltran [Entered: 10/10/2025 10:31 PM] |
| Filing 36 CERTIFICATE OF CONFIDENTIALITY (Local Rule 25(c)) by Meritain Health, Inc. in 25-1828, ProAct, Inc. in 25-1829, Advanced Pharmacy, LLC, Aqua Enterprise Inc. and RX Valet, LLC in 25-1849, Gregory Santulli in 25-1850. Sealing Required: Yes. Description of document referenced by certificate: 25-1828(L) JA Vols 07-13 - Sealed. [1001858648] [25-1828, 25-1829, 25-1849, 25-1850] Jonathan Garlough [Entered: 10/10/2025 02:18 PM] |
| Filing 35 SEALED JOINT APPENDIX VOLUME(S) (court access) by Meritain Health, Inc. in 25-1828, ProAct, Inc. in 25-1829, Advanced Pharmacy, LLC, Aqua Enterprise Inc. and RX Valet, LLC in 25-1849, Gregory Santulli in 25-1850. Digital media exhibit volume? No. Filed Ex parte: N. [1001858646] [25-1828, 25-1829, 25-1849, 25-1850]--[Edited 12/10/2025 by RP - volume 10 replaced to correct missing pages] Jonathan Garlough [Entered: 10/10/2025 02:16 PM] |
| Filing 34 JOINT APPENDIX by Meritain Health, Inc. in 25-1828, ProAct, Inc. in 25-1829, Advanced Pharmacy, LLC, Aqua Enterprise Inc. and RX Valet, LLC in 25-1849, Gregory Santulli in 25-1850. Digital media exhibit volume? No. [1001858623] [25-1828, 25-1829, 25-1849, 25-1850]--[Edited 10/10/2025 by RP - party filers updated] Jonathan Garlough [Entered: 10/10/2025 02:01 PM] |
| Filing 33 BRIEF by Meritain Health, Inc. in 25-1828, ProAct, Inc. in 25-1829. Type of Brief: OPENING. . Do any cases pending in this court or the Supreme Court of the United States raise similar issues? NO.. [1001858609] [25-1828, 25-1829, 25-1849, 25-1850] Jonathan Garlough [Entered: 10/10/2025 01:52 PM] |
Filing 32
ORDER filed granting motion to extend filing time [ # 30 ]. Opening briefs and appendix due 10/10/2025. Response briefs due 12/05/2025. Reply brief due 01/09/2026. No paper copies required unless case has been tentatively calendared or copies otherwise ordered. Copies to all parties. [1001845566] [25-1828, 25-1829, 25-1849, 25-1850] EB [Entered: 09/19/2025 03:14 PM]
|
| Filing 31 COURT ORDER filed granting in part motion to file separate briefs [ # 25 ]. Copies to all parties. [1001845548] [25-1828, 25-1829, 25-1849, 25-1850] EB [Entered: 09/19/2025 03:04 PM] |
| Filing 30 MOTION by Meritain Health, Inc. in 25-1828, ProAct, Inc. in 25-1829, Advanced Pharmacy, LLC, Aqua Enterprise Inc. and RX Valet, LLC in 25-1849, Gregory Santulli in 25-1850 to extend filing time for opening brief and appendix.. Date and method of service: 09/18/2025 ecf. [1001844604] [25-1828, 25-1829, 25-1849, 25-1850] Todd Hesel [Entered: 09/18/2025 11:35 AM] |
| Filing 29 REPLY by Meritain Health, Inc. in 25-1828, ProAct, Inc. in 25-1829, Advanced Pharmacy, LLC, Aqua Enterprise Inc. and RX Valet, LLC in 25-1849, Gregory Santulli in 25-1850 to response [ # 28 ].. [1001833372] [25-1828, 25-1829, 25-1849, 25-1850] Todd Hesel [Entered: 09/02/2025 12:26 PM] |
| Filing 28 RESPONSE/ANSWER by Gilead Sciences Ireland UC IDA and Gilead Sciences, Inc. in 25-1828, 25-1829, 25-1849, 25-1850 to notice requesting response [ # 26 ], Motion [ # 25 ]. Nature of response: in opposition. [1001829333] [25-1828, 25-1829, 25-1849, 25-1850] Geoffrey Potter [Entered: 08/25/2025 06:33 PM] |
Filing 27
ORDER filed granting motion to extend briefing order deadlines. Opening brief and appendix due 09/30/2025. Response brief due 12/05/2025. No paper copies required unless case has been tentatively calendared or copies otherwise ordered. Copies to all parties. [1001823277] [25-1828, 25-1829, 25-1849, 25-1850] RP [Entered: 08/15/2025 09:49 AM]
|
| Filing 26 NOTICE ISSUED to Gilead Sciences Ireland UC IDA and Gilead Sciences, Inc. in 25-1828, 25-1829, 25-1849, 25-1850 requesting response to Motion for other relief [ # 25 ]. Response due 08/25/2025[1001823272]. [25-1828, 25-1829, 25-1849, 25-1850] RP [Entered: 08/15/2025 09:44 AM] |
| Filing 25 MOTION by Meritain Health, Inc. in 25-1828, ProAct, Inc. in 25-1829, Advanced Pharmacy, LLC, Aqua Enterprise Inc. and RX Valet, LLC in 25-1849, Gregory Santulli in 25-1850 to extend briefing schedule and file separate briefs. Date and method of service: 08/14/2025 ecf. [1001822922] [25-1828, 25-1829, 25-1849, 25-1850].--[Edited 09/02/2025 by AB to modify relief and docket text] Jonathan Garlough [Entered: 08/14/2025 02:47 PM] |
| Filing 24 DISCLOSURE STATEMENT by RX Valet, LLC in 25-1849. Was any question on Disclosure Form answered yes? No [1001818831] [25-1849, 25-1828, 25-1829, 25-1850] Michael Beltran [Entered: 08/06/2025 07:40 PM] |
| Filing 23 DISCLOSURE STATEMENT by Aqua Enterprise Inc. in 25-1849. Was any question on Disclosure Form answered yes? No [1001818830] [25-1849, 25-1828, 25-1829, 25-1850] Michael Beltran [Entered: 08/06/2025 07:39 PM] |
| Filing 22 DISCLOSURE STATEMENT by Advanced Pharmacy, LLC in 25-1849. Was any question on Disclosure Form answered yes? No [1001818829] [25-1849, 25-1828, 25-1829, 25-1850] Michael Beltran [Entered: 08/06/2025 07:38 PM] |
| Filing 21 APPEARANCE OF COUNSEL by Michael P. Beltran for Advanced Pharmacy, LLC, Aqua Enterprise Inc. and RX Valet, LLC in 25-1849, Gregory Santulli in 25-1850. [1001818828] [25-1849, 25-1828, 25-1829, 25-1850] Michael Beltran [Entered: 08/06/2025 07:35 PM] |
| Filing 20 APPEARANCE OF COUNSEL by Michael Blumenfeld for Advanced Pharmacy, LLC, RX Valet, LLC and Aqua Enterprise Inc. in 25-1849, Gregory Santulli in 25-1850. [1001818436] [25-1828, 25-1829, 25-1849, 25-1850] Michael Blumenfeld [Entered: 08/06/2025 12:52 PM] |
| Filing 19 APPEARANCE OF COUNSEL by Jennifer W. Winkler for Advanced Pharmacy, LLC, RX Valet, LLC and Aqua Enterprise Inc. in 25-1849, Gregory Santulli in 25-1850. [1001818400] [25-1828, 25-1829, 25-1849, 25-1850] Jennifer Winkler [Entered: 08/06/2025 12:34 PM] |
| Filing 18 DISCLOSURE STATEMENT by Gregory Santulli in 25-1850. Was any question on Disclosure Form answered yes? No [1001818397] [25-1828, 25-1829, 25-1849, 25-1850] Rachel Hedley [Entered: 08/06/2025 12:31 PM] |
| Filing 17 APPEARANCE OF COUNSEL by Rachel Hedley for Advanced Pharmacy, LLC, RX Valet, LLC and Aqua Enterprise Inc. in 25-1849, Gregory Santulli in 25-1850. [1001818378] [25-1828, 25-1829, 25-1849, 25-1850] Rachel Hedley [Entered: 08/06/2025 12:22 PM] |
| Filing 16 DOCKETING STATEMENT by ProAct, Inc... [1001817011] [25-1829] Todd Hesel [Entered: 08/04/2025 04:09 PM] |
| Filing 15 DISCLOSURE STATEMENT by Gilead Sciences, Inc. in 25-1828, 25-1829, 25-1849, 25-1850. Was any question on Disclosure Form answered yes? Yes [1001815258] [25-1828, 25-1829, 25-1849, 25-1850] Geoffrey Potter [Entered: 07/31/2025 01:17 PM] |
| Filing 14 DISCLOSURE STATEMENT by Gilead Sciences Ireland UC IDA in 25-1828, 25-1829, 25-1849, 25-1850. Was any question on Disclosure Form answered yes? Yes [1001815250] [25-1828, 25-1829, 25-1849, 25-1850] Geoffrey Potter [Entered: 07/31/2025 01:15 PM] |
| Filing 13 APPEARANCE OF COUNSEL by Timothy A. Waters for Gilead Sciences Ireland UC IDA and Gilead Sciences, Inc. in 25-1828, 25-1829, 25-1849, 25-1850. [1001815220] [25-1828, 25-1829, 25-1849, 25-1850] Timothy Waters [Entered: 07/31/2025 01:05 PM] |
| Filing 12 APPEARANCE OF COUNSEL by Tara J. Norris for Gilead Sciences Ireland UC IDA and Gilead Sciences, Inc. in 25-1828, 25-1829, 25-1849, 25-1850. [1001815213] [25-1828, 25-1829, 25-1849, 25-1850] Tara Janelle Norris [Entered: 07/31/2025 01:03 PM] |
| Filing 11 APPEARANCE OF COUNSEL by Geoffrey Potter for Gilead Sciences Ireland UC IDA and Gilead Sciences, Inc. in 25-1828, 25-1829, 25-1849, 25-1850. [1001815205] [25-1828, 25-1829, 25-1849, 25-1850] Geoffrey Potter [Entered: 07/31/2025 12:59 PM] |
| Filing 10 APPEARANCE OF COUNSEL by Jonathan W. Garlough for Meritain Health, Inc. in 25-1828. [1001815066] [25-1828, 25-1829, 25-1849, 25-1850] Jonathan Garlough [Entered: 07/31/2025 11:37 AM] |
| Filing 9 Attorney Gregg Lewis Bernstein for Gilead Sciences, Inc. and Gilead Sciences Ireland UC IDA in 25-1828, Gilead Sciences, Inc. and Gilead Sciences Ireland UC IDA in 25-1829, Gilead Sciences, Inc. and Gilead Sciences Ireland UC IDA in 25-1849 and Gilead Sciences, Inc. and Gilead Sciences Ireland UC IDA in 25-1850 terminated from case. Reason for termination: Not participating. [1001812323] [25-1828, 25-1829, 25-1849, 25-1850] RP [Entered: 07/28/2025 02:17 PM] |
| Filing 8 Amended BRIEFING ORDER filed. Mailed to: Rhick Bose, Jarren Neil Ginsburg, Todd William Hesel,Jillian F. Horowitz, Nathaniel Lancaster, Ellen A. Matheson, Ilona Shparaga, Anastasia Wagner and Timothy A. Waters. No paper copies required unless case has been tentatively calendared or copies otherwise ordered. All filings must comply with # Appendix Pagination & Brief Citation Guide . [1001812303] Opening Brief and Appendix due 09/08/2025. Response Brief due 10/08/2025. [25-1828, 25-1829, 25-1849, 25-1850] RP [Entered: 07/28/2025 02:01 PM] |
Filing 7
ORDER filed consolidating case 25-1829, 25-1849, 25-1850 with 25-1828. Copies to all parties. Mailed to: Rhick Bose, Jarren Neil Ginsburg, Todd William Hesel,Jillian F. Horowitz, Nathaniel Lancaster, Ellen A. Matheson, Ilona Shparaga, Anastasia Wagner and Timothy A. Waters. [1001812297] [25-1828, 25-1829, 25-1849, 25-1850] RP [Entered: 07/28/2025 01:56 PM]
|
| Filing 6 DISCLOSURE STATEMENT by ProAct, Inc. in 25-1829. Was any question on Disclosure Form answered yes? Yes [1001808653] [25-1828, 25-1829] Todd Hesel [Entered: 07/22/2025 01:39 PM] |
| Filing 5 APPEARANCE OF COUNSEL by Todd W. Hesel, William N. Sinclair and Ilona Shparaga for ProAct, Inc. in 25-1829. [1001808649] [25-1828, 25-1829] Todd Hesel [Entered: 07/22/2025 01:38 PM] |
| Filing 4 BRIEFING ORDER filed. Mailed to: Rhick Bose, Jarren Neil Ginsburg, Jillian F. Horowitz, Nathaniel Lancaster, Ellen A. Matheson, Tara J. Norris, Geoffrey Potter, and Timothy A. Waters. No paper copies required unless case has been tentatively calendared or copies otherwise ordered. All filings must comply with # Appendix Pagination & Brief Citation Guide . [1001807685] Opening Brief and Appendix due 09/02/2025. Response Brief due 10/02/2025. [25-1828, 25-1829] RP [Entered: 07/21/2025 12:48 PM] |
Filing 3
ORDER filed consolidating case 25-1829 with 25-1828. Copies to all parties. Mailed to: Rhick Bose, Jarren Neil Ginsburg, Jillian F. Horowitz, Nathaniel Lancaster, Ellen A. Matheson, Tara J. Norris, Geoffrey Potter, and Timothy A. Waters. [1001807663] [25-1828, 25-1829] RP [Entered: 07/21/2025 12:35 PM]
|
| Filing 2 DOCKETING NOTICE issued Re: [ # 1 ] case. Originating case number: 1:24-cv-03566-JRR. Mailed to: Rhick Bose, Jarren Neil Ginsburg, Jillian F. Horowitz, Nathaniel Lancaster, Ellen A. Matheson, Tara J. Norris, Geoffrey Potter, and Timothy A. Waters. [1001807658] [25-1829] RP [Entered: 07/21/2025 12:31 PM] |
| Filing 1 Case docketed. Originating case number: 1:24-cv-03566-JRR. Case manager: RachelPhillips. [1001807644] [25-1829] RP [Entered: 07/21/2025 12:21 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.